Mono-allelic expression of the IGF-I receptor does not affect IGF responses in human fibroblasts.

OBJECTIVE It has been suggested that mono-allelic deletion of the IGF-I receptor gene is causally related to severe intrauterine and postnatal growth deficiency whereas no IGF-I resistance was observed in the patients' fibroblasts. The expression and regulation of the growth-modulating IGF binding proteins (IGFBPs) have been investigated in serum and fibroblasts of a short girl with mono-allelic loss of the distal long arm of chromosome 15 (15q26.1-qter). PATIENT AND METHODS The mono-allelic loss of the IGF-I receptor (IGF1R) gene was confirmed in a child with prenatal and severe postnatal growth retardation by fluorescence in situ hybridization, and was evaluated on the protein level in fibroblasts of the patient by FACS analysis and IGF cross-linkage. Additionally, expression of IGFBPs and cell-mediated degradation of IGFBP-3 were examined in the patient's fibroblasts. RESULTS Levels of GH, IGF-I, and IGFBP-3 were above the 95th percentile in the serum of the 3-year-old girl with a mono-allelic deletion of the IGF1R gene, suggesting IGF-I resistance. In the patient's fibroblasts the IGF-I receptor concentration was half that in control cells. Whereas the pattern of secreted IGFBPs in response to IGFs was not altered, the abundance of secreted IGFBPs was higher in the patient's cells than in controls. Moreover, fibroblast-mediated degradation of 125I-labeled IGFBP-3 appears to be reduced in the patient's fibroblasts. The higher abundance of IGFBPs in the patient's fibroblasts might be responsible for the lack of IGF-I-stimulated [alpha-1-14C]methylaminoisobutyric acid transport. CONCLUSION Our results suggest that the expression and regulation of IGFBPs in tissues from patients with mono-allelic deletion of the IGF-I receptor gene may lead to IGF sequestration and contribute to IGF-I resistance and growth retardation.

[1]  E. Flori,et al.  Interstitial deletion of chromosome 15: two cases , 1988, Human Genetics.

[2]  C. Lautier,et al.  IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. , 2003, The New England journal of medicine.

[3]  D. Dunger,et al.  Cell proliferation activities on skin fibroblasts from a short child with absence of one copy of the type 1 insulin-like growth factor receptor (IGF1R) gene and a tall child with three copies of the IGF1R gene. , 2003, The Journal of clinical endocrinology and metabolism.

[4]  J. Wit,et al.  Genetic Analysis of Short Stature , 2003, Hormone Research in Paediatrics.

[5]  S. Mohan,et al.  ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts. , 2002, Biochemistry.

[6]  R. Baxter,et al.  Cellular actions of the insulin-like growth factor binding proteins. , 2002, Endocrine reviews.

[7]  N. Niikawa,et al.  Postnatal overgrowth by 15q-trisomy and intrauterine growth retardation by 15q-monosomy due to familial translocation t(13;15): dosage effect of IGF1R? , 2002, American journal of medical genetics.

[8]  T. Braulke,et al.  Isolation and characterization of circulating fragments of the insulin‐like growth factor binding protein‐3 , 2002, FEBS letters.

[9]  H. Nakano,et al.  IGF-Related Proteins at Birth in a Case of Antenatally Diagnosed Silver-Russell Syndrome , 2002, Pediatric Research.

[10]  Víctor Quesada,et al.  Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains. , 2002, Gene.

[11]  H. Hennies,et al.  De novo terminal deletion of chromosome 15q26.1 characterised by comparative genomic hybridisation and FISH with locus specific probes , 2001, Journal of medical genetics.

[12]  S. Yakar,et al.  The somatomedin hypothesis: 2001. , 2001, Endocrine reviews.

[13]  F. Loechel,et al.  ADAM 12, a Disintegrin Metalloprotease, Interacts with Insulin-like Growth Factor-binding Protein-3* , 2000, The Journal of Biological Chemistry.

[14]  H. Werner,et al.  In vitro and in vivo responses to short‐term recombinant human insulin‐like growth factor‐1 (IGF‐I) in a severely growth‐retarded girl with ring chromosome 15 and deletion of a single allele for the type 1 IGF receptor gene , 1999, Clinical endocrinology.

[15]  L. Maile,et al.  Insulin-like growth factor binding protein (IGFBP) proteolysis: occurrence, identification, role and regulation. , 1999, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[16]  S. Weinzimer,et al.  Cellular Actions of Insulin-Like Growth Factor Binding Proteins , 1999, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[17]  D. Constam,et al.  Failure of ventral closure and axial rotation in embryos lacking the proprotein convertase Furin. , 1998, Development.

[18]  F. Minuto,et al.  Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy. , 1998, The Journal of clinical endocrinology and metabolism.

[19]  F. André,et al.  Deficient processing and activity of type I insulin-like growth factor receptor in the furin-deficient LoVo-C5 cells. , 1998, Endocrinology.

[20]  M. Savage,et al.  Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. , 1996, The New England journal of medicine.

[21]  T. Braulke,et al.  Immunohistochemical localization of insulin-like growth factor binding protein-1, -3 and -4 in human fetal tissues and their analysis in media from fetal tissue explants. , 1996, Growth regulation.

[22]  D. J. Driscoll,et al.  Distinct 15q genotypes in Russell-Silver and ring 15 syndromes. , 1996, American journal of medical genetics.

[23]  K. Blakemore,et al.  Insulin-like growth factor I receptor expression and function in fibroblasts from two patients with deletion of the distal long arm of chromosome 15. , 1995, The Journal of clinical endocrinology and metabolism.

[24]  M. Lewitt,et al.  Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice. , 1995, Endocrinology.

[25]  C T Roberts,et al.  Molecular and cellular aspects of the insulin-like growth factor I receptor. , 1995, Endocrine reviews.

[26]  D. Clemmons,et al.  Insulin-like growth factors and their binding proteins: biological actions. , 1995, Endocrine reviews.

[27]  T. Braulke,et al.  Mannose 6-Phosphate/Insulin-like Growth Factor II Receptor Fails to Interact with G-proteins , 1995, The Journal of Biological Chemistry.

[28]  C. Stroh,et al.  Recombinant human insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats. , 1994, Endocrinology.

[29]  L. Powell-Braxton,et al.  IGF-I is required for normal embryonic growth in mice. , 1993, Genes & development.

[30]  J. Baker,et al.  Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) , 1993, Cell.

[31]  J. Wallace,et al.  Insulin-like growth factor (IGF)-II binding to IGF-binding proteins and IGF receptors is modified by deletion of the N-terminal hexapeptide or substitution of arginine for glutamate-6 in IGF-II. , 1993, The Biochemical journal.

[32]  D. Clemmons,et al.  Competition for binding to insulin-like growth factor (IGF) binding protein-2, 3, 4, and 5 by the IGFs and IGF analogs. , 1992, Endocrinology.

[33]  W. Daughaday,et al.  Endogenous insulin-like growth factor (IGF) binding proteins cause IGF-1 resistance in cultured fibroblasts from a patient with short stature. , 1991, The Journal of clinical investigation.

[34]  M. Chrétien,et al.  An infant with deletion of the distal long arm of chromosome 15 (q26.1----qter) and loss of insulin-like growth factor 1 receptor gene. , 1991, American journal of medical genetics.

[35]  A. Efstratiadis,et al.  A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting , 1990, Nature.

[36]  C. Dozier,et al.  Interstitial deletion of the long arm of chromosome 11. , 1987, Annales de genetique.

[37]  N. Mandahl,et al.  Monosomy and trisomy of 15q24→qter in a family with a translocation t(6;15)(P25;q24) , 1987, Clinical genetics.

[38]  R. Clark.  Del(15)(q22q24) syndrome with Potter sequence. , 1984, American journal of medical genetics.

[39]  K. Parker,et al.  Localization of the sites of iodination of human beta 2-microglobulin: quaternary structure implications for histocompatibility antigens. , 1983, Biochemistry.

[40]  J. Fryns,et al.  Interstitial deletion of the long arm of chromosome 15. , 1982, Annales de genetique.

[41]  O. Zuffardi,et al.  Tandem translocation 15-13. , 1973, Annales de genetique.